| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.06. | Nurix Therapeutics, Inc.: Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) | 177 | GlobeNewswire (Europe) | Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK inhibitor resistance mutations Clinical responses in CLL patients were rapid and deepening... ► Artikel lesen | |
| 16.06. | Regeneron Pharmaceuticals, Inc.: Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma | 257 | GlobeNewswire (Europe) | At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71% overall response rate, as presented in an EHA oral presentation and simultaneously... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| SUPER MICRO COMPUTER | 2.914 |
| EVOTEC | 2.166 |
| TUI | 1.841 |
| BAYER | 1.789 |
| NVIDIA | 1.672 |
| NEL | 1.274 |
| RENK GROUP | 1.139 |
| RHEINMETALL | 1.040 |
| TESLA | 876 |
| PALANTIR TECHNOLOGIES | 828 |
| DEUTSCHE BANK | 773 |
| VOLKSWAGEN | 747 |
| MICROSTRATEGY | 714 |
| BYD | 697 |
| PLUG POWER | 661 |
| COMMERZBANK | 656 |
| BASF | 632 |
| JINKOSOLAR | 616 |
| MERCEDES-BENZ | 593 |
| AMAZON | 575 |
| DEUTSCHE TELEKOM | 553 |
| INTEL | 550 |
| BMW | 544 |
| ALLIANZ | 537 |
| THYSSENKRUPP | 534 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
